Investor profile
Anja König
Corporate VC, Government-backed & Director Board of Directors at Innosuisse, Global Head Novartis Venture Fund at Novartis
Anja König is a Global Head Novartis Venture Fund at Novartis, whose known portfolio counts 16 companies.
Is Anja König a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHardwareHealthcare
- Focus
- BiotechCell & Gene TherapyDiagnosticsDrug DiscoveryGenomicsImmunologyMachine LearningMedTechMedical DevicesOncologyPharmaRoboticsSemiconductors
Contacts
Affiliated funds' portfolios
Director Board of Directors at Innosuisse, whose known portfolio counts 10 companies
- Chiral
- Cellvie
- Lighthouse Tech
- Unbound Potential
- Dexterous Endoscopes
- Sparkli
- EVis Bioscience
- OrthoSens
- Reverso Therapeutics
- Deegtal
Global Head Novartis Venture Fund at Novartis, whose known portfolio counts 16 companies
- Octave
- Vor Biopharma
- Patientory
- Orna Therapeutics
- Pliant Therapeutics
- TScan Therapeutics
- CatalYm
- Dren Bio
- Surface Oncology
- Cadent Therapeutics
- Flare Therapeutics
- Medtech Africa
- and 4 more
Investor Profile
Founders in the listed sectors AI, Hardware and Healthcare, and focus areas Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery fall inside that listing.
Stage-wise, the deals at Novartis cluster around Growth, Pre-Seed and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Anja König is worth approaching.
Colleagues
Balz Roth
Startup Coach
Zürich, Switzerland
Paolo Malerba
Strategy Lead
London, United Kingdom
Nicole Herzog
Member of the Innovation Council Innosuisse
Switzerland
Thomas Estier
Innovation Mentor
Düdingen, Switzerland
Jose Marcilla
President Latin America and Canada (LACan) Region
United States
Bolko Hohaus
Innosuisse Startup Coach
Geneva, Switzerland
David Alain Bloch
Investor
Zürich, Switzerland
Beat Steffen
Managing Director Novartis Venture Fund
Basel, Switzerland
Marianne Uteng
Managing Director
Basel, Switzerland
Jason Freeman
Senior Medical Director
Washington, United States
Markus Goebel
Investor
Switzerland
Shejoy Varghese
Managing partner
Ernakulam, India
Marc Ceulemans
Head, Strategic Venture Capital Fund
Laax, Switzerland
Md. Sohel Rana
Managing Partner
Bangladesh
Steven Breazzano
Investor
Fairfield, United States
Nicolas Loeillot
Investor
Lausanne, Switzerland
Lauren Silverman
Managing Director
Cambridge, United States
Stefanie D.
Portfolio Reporting Director
Zürich, Switzerland
Max Meister
Scale-up Coach
Zürich, Switzerland
Simone Riedel Riley
Member of the Innovation Council Innosuisse
Zürich, Switzerland
Frequently asked questions
Who is Anja König?
Anja König is a corporate venture investor and government-backed investor based in Basel, Switzerland, listed as Global Head Novartis Venture Fund at Novartis. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Anja König personally.
What does Anja König invest in?
Listed sectors include AI, Hardware and Healthcare; listed focus areas include Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Anja König invest at?
Novartis appears in Growth, Pre-Seed and Seed rounds across its known deals, and Anja König is listed there as Global Head Novartis Venture Fund. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Anja König listed at?
Anja König is listed as Global Head Novartis Venture Fund at Novartis. 20 other people in the database share a firm with Anja König.
How do I contact Anja König?
An email address, a phone number and a LinkedIn page are on file for Anja König. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal